Gonçalo Bernardes
About Gonçalo Bernardes
Gonçalo Bernardes is a prominent scientist and academic specializing in chemical biology, currently serving as Associate Editor for Bioconjugate Chemistry and holding various positions in research and advisory roles across multiple institutions.
Work at American Chemical Society
Gonçalo Bernardes serves as an Associate Editor for Bioconjugate Chemistry at the American Chemical Society. He has held this position since 2023, contributing to the publication's focus on the intersection of chemistry and biology. His role involves overseeing the peer review process, managing submissions, and ensuring the quality of published research in the field.
Education and Expertise
Gonçalo Bernardes earned a Master's degree in Chemistry from the University of Lisbon between 1999 and 2004. He furthered his education at the University of Oxford, where he achieved a D. Phil in Chemical Biology from 2004 to 2008. His academic background provides a strong foundation for his extensive work in chemical biology and related fields.
Background
Gonçalo Bernardes has a diverse professional background, having worked in various prestigious institutions. He was an Associate Professor of Chemical Biology at the University of Cambridge's Yusuf Hamied Department of Chemistry from 2019 to 2022. He has also held positions at ETH Zürich and the Instituto de Medicina Molecular, demonstrating his commitment to advancing research in chemical biology.
Achievements
Gonçalo Bernardes has made significant contributions to the field of chemical biology through various roles. He has served on multiple editorial advisory boards, including those for Chemical Society Reviews and ACS Central Science. His involvement in scientific advisory boards, such as Proterris, Inc. and Transition Bio, Inc., showcases his influence in guiding research and development in the industry.
Current Roles and Responsibilities
As of 2023, Gonçalo Bernardes holds multiple positions, including Scientific Co-Founder and Chairman at TargTex, Head of Translational Chemical Biology at Instituto de Medicina Molecular, and Professor of Chemical Biology at the University of Cambridge. His role as Co-founder and CTO at Proteotype Diagnostics further emphasizes his active engagement in the scientific community and innovation in biotechnology.